BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27150392)

  • 1. Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.
    Liu J; Hernandez-Ono A; Graham MJ; Galton VA; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1356-66. PubMed ID: 27150392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 3,5,3'-Triiodothyronine (T3) administration on dio1 gene expression and T3 metabolism in normal and type 1 deiodinase-deficient mice.
    Maia AL; Kieffer JD; Harney JW; Larsen PR
    Endocrinology; 1995 Nov; 136(11):4842-9. PubMed ID: 7588215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
    Du Y; Wang L; Si S; Yang Y; Hong B
    Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression.
    Bruinstroop E; Zhou J; Tripathi M; Yau WW; Boelen A; Singh BK; Yen PM
    Mol Metab; 2021 Nov; 53():101266. PubMed ID: 34098145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
    Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
    J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Type 1 Iodothyronine Deiodinase (
    França MM; German A; Fernandes GW; Liao XH; Bianco AC; Refetoff S; Dumitrescu AM
    Thyroid; 2021 Feb; 31(2):202-207. PubMed ID: 32718224
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
    Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
    J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
    Guo Y; Fan Y; Zhang J; Lomberk GA; Zhou Z; Sun L; Mathison AJ; Garcia-Barrio MT; Zhang J; Zeng L; Li L; Pennathur S; Willer CJ; Rader DJ; Urrutia R; Chen YE
    J Clin Invest; 2015 Oct; 125(10):3819-30. PubMed ID: 26368306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
    Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
    J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
    Mikael LG; Genest J; Rozen R
    Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9.
    Ohguchi H; Tanaka T; Uchida A; Magoori K; Kudo H; Kim I; Daigo K; Sakakibara I; Okamura M; Harigae H; Sasaki T; Osborne TF; Gonzalez FJ; Hamakubo T; Kodama T; Sakai J
    Mol Cell Biol; 2008 Jun; 28(12):3917-31. PubMed ID: 18426912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).
    Srivastava J; Robertson CL; Gredler R; Siddiq A; Rajasekaran D; Akiel MA; Emdad L; Mas V; Mukhopadhyay ND; Fisher PB; Sarkar D
    J Biol Chem; 2015 Jun; 290(25):15549-15558. PubMed ID: 25944909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.
    Bailey D; Jahagirdar R; Gordon A; Hafiane A; Campbell S; Chatur S; Wagner GS; Hansen HC; Chiacchia FS; Johansson J; Krimbou L; Wong NC; Genest J
    J Am Coll Cardiol; 2010 Jun; 55(23):2580-9. PubMed ID: 20513599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.